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In the search for modifiable determinants of breast cancer, dietary
factors are an ongoing focus of research. Migrant studies (Buell,
1973; Thomas and Karagas, 1987; Shimizu et al, 1991; Ziegler et
al, 1993) support the hypothesis that diet or other lifestyle factors
may partially explain the international differences in breast cancer
incidence, and experimental data demonstrate that dietary factors
may enhance or inhibit mammary carcinogenesis in animals
(Tannenbaum, 1942; Albanes, 1987). Dietary factors explored as
potentially protective for breast cancer include vitamins A, C and
E. Vitamin A, from retinol (preformed vitamin A) or provitamin A
carotenoids, plays a role in epithelial cell differentiation and
control of proliferation (Sporn and Roberts, 1983). In addition,
carotenoids act as antioxidants (Peto et al, 1981; Ames, 1983), as
do vitamin C and vitamin E (Ames, 1983).
The epidemiological evidence regarding intake of these
micronutrients and risk of breast cancer is strongest for carotenoids
and vitamin C, although for both nutrients the associations
observed in case–control studies have generally been stronger than
the results observed in cohort studies. Inverse associations with
vitamin E have also been observed in a number of case–control
studies, but most prospective studies have reported null findings.
Results for retinol intake have also been mixed. These and other
nutrients have been reviewed by Hunter and Willett (1996).
The present study assesses the intake of retinol, b-carotene,
vitamin C and vitamin E in relation to the risk of breast cancer in a
case–control study in Greece. A question of interest is the extent to
which any association observed with these micronutrients can be
attributed to the nutrients per se rather than to other unmeasured
components of fruits and vegetables.
MATERIALS AND METHODS
During a 3-year period from January 1989 until December 1991,
all women with newly diagnosed breast cancer who were residents
of the greater Athens area (Athens, Piraeus and surroundings;
population about 3.5 million) were identified from four major
hospitals. These four hospitals account for approximately 50% of
all breast cancer cases occurring in this area. Of a total of 873
histologically confirmed cases, 820 (94%) were successfully inter-
viewed and included in this study. All interviews took place in the
hospital before the first discharge.
Two controls were selected for each case, one from among
hospital visitors to the same hospital and one from among
orthopaedic patients at the major accident hospital in Athens (for
breast cancer cases residing in or around Athens) or Piraeus (for
breast cancer cases residing in or around Piraeus). Controls were
selected from among women of the same age (within 5 years) and
residential area as the index case. A total of 808 eligible visitor
controls and 830 eligible orthopaedic patient controls were identi-
fied; of these, 753 (93%) of the visitor controls and 795 (96%) of
the orthopaedic patient controls were interviewed and included in
the study. Control interviews were conducted in the hospital by the
same interviewer who interviewed the index case. Additional
information regarding subject selection has been presented else-
where (Katsouyanni et al, 1994a).
The interview included demographic, socioeconomic, reproduc-
tive and biomedical variables, as well as a semiquantitative food
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subjects were asked to indicate their average intake of 115 food
items per day, week or month during the year before the present
disease (or the interview for visitor controls). A version of this
questionnaire has been validated (Gnardellis et al, 1995;
Katsouyanni et al, 1997). For the purpose of analysis, the intake of
each food item was quantified approximately as the number of
times the food was consumed per month, as it was by Graham et al
(1978) and Katsouyanni et al (1991a). Thus, daily intake was
multiplied by 30 and weekly intake by 4; food items consumed
rarely or never were given a value of 0.
Intake of specific nutrients was estimated by multiplying the
nutrient content of a selected typical portion of each food item by
the frequency the food item was eaten per month and summing
over all food items. Food consumption data were based on a
nutrient database developed in Greece by the Department of
Nutrition and Biochemistry, Athens School of Public Health
(Trichopoulou, 1992). The portion size estimation was based on
the results from previous validation studies (Katsouyanni et al,
1991b; Gnardellis et al, 1995), and the nutrient content was calcu-
lated on the basis of Greek recipes (Trichopoulou, 1992). Vitamin
supplement use was very uncommon in this population. Because
of the positive correlation between intake of most nutrients and
total energy intake, multivariate models include total energy intake
as a potential confounder. Analyses of fat and other macronutri-
ents, alcohol intake and specific food groups have been presented
in earlier reports (Katsouyanni et al, 1994a, 1994b; Trichopoulou
et al, 1995), but the associations, if any, with micronutrients such
as vitamins A and C have not been previously examined.
Results were modelled by unconditional logistic regression
(Breslow and Day, 1980) using the SAS statistical package (SAS
Institute, Cary, NC, USA). Although cases and controls were
paired with respect to age, place of residence and interviewer, this
was done essentially for administrative purposes, to facilitate
enrolment of cases and controls in an operationalized way that
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Table 1 Distribution of 820 breast cancer cases and 1548 controlsa by
demographic and reproductive variablesb
Cases Controls
Age (years) 56.4 (0.43)c 54.4 (0.32)
Place of birth
Urban 620 (75.7) 1106 (71.6)
Rural 199 (24.3) 439 (28.4)
Age at menarche (years) 12.9 (0.06) 13.1 (0.04)
Quetelet index (kg m–2) 26.6 (1.02) 25.9 (0.75)
Ever pregnant
Yes 657 (80.2) 1164 (75.2)
No 162 (19.8) 384 (24.8)
Age at first birth (years) 26.4 (0.21) 25.9 (0.16)
Menopausal status
Post-menopausal 550 (67.1) 1041 (67.3)
Premenopausal 270 (32.9) 505 (32.7)
aThere are a few missing values. bAdapted from Katsouyanni et al (1994a).
cNumbers in parentheses are standard errors for quantitative variables and
percentages for qualitative variable.
Table 2 Frequency distribution of breast cancer cases and controls by quintile of intakea of selected micronutrients, among all women and stratified by
menopausal statusb
Micronutrient All women Premenopausal women Post-menopausal women
Cases (%) Controls (%) Cases (%) Controls (%) Cases (%) Controls (%)
Retinol (mg day–1)
≤659.1 159 (19.4) 310 (20.0) 34 (12.6) 69 (13.7) 125 (22.8) 241 (23.2)
659.2–1306.3 169 (20.6) 309 (20.0) 47 (17.4) 79 (15.6) 122 (22.2) 228 (21.9)
1306.4–1575.2 170 (20.8) 309 (20.0) 55 (20.4) 100 (19.8) 115 (21.0) 209 (20.1)
1575.3–2120.7 155 (18.9) 309 (20.0) 60 (22.2) 115 (22.8) 95 (17.3) 194 (18.7)
>2120.7 166 (20.3) 310 (20.0) 74 (27.4) 142 (28.1) 92 (16.8) 168 (16.2)
b-Carotene (mg day–1)
≤3780.7 195 (23.8) 309 (20.0) 62 (23.0) 83 (16.4) 133 (24.2) 225 (21.6)
3780.8–5185.6 178 (21.7) 310 (20.0) 52 (19.3) 89 (17.6) 126 (23.0) 221 (21.3)
5185.7–6465.4 143 (17.5) 310 (20.0) 59 (21.9) 97 (19.2) 84 (15.3) 212 (20.4)
6465.5–8362.4 154 (18.8) 309 (20.0) 52 (19.3) 114 (22.6) 102 (18.6) 195 (18.8)
>8362.4 149 (18.2) 309 (20.0) 45 (16.7) 122 (24.2) 104 (18.9) 187 (18.0)
Vitamin C (mg day–1)
≤142.9 162 (19.8) 310 (20.0) 41 (15.2) 70 (13.9) 121 (22.0) 240 (23.1)
143.0–212.0 203 (24.8) 310 (20.0) 65 (24.1) 94 (18.6) 138 (25.1) 215 (20.7)
212.1–274.0 163 (19.9) 309 (20.0) 59 (21.9) 90 (17.8) 104 (18.9) 218 (20.9)
274.1–343.1 151 (18.4) 310 (20.0) 52 (19.3) 110 (21.8) 99 (18.0) 200 (19.2)
>343.1 140 (17.1) 309 (20.0) 53 (19.6) 141 (27.9) 87 (15.9) 168 (16.1)
Vitamin E (IU day–1)
≤5.2 171 (20.9) 310 (20.0) 33 (12.2) 58 (11.5) 138 (25.1) 251 (24.1)
5.3–6.2 174 (21.3) 309 (20.0) 55 (20.4) 96 (19.0) 119 (21.7) 213 (20.5)
6.3–7.2 165 (20.2) 310 (20.0) 66 (24.4) 91 (18.0) 99 (18.0) 218 (21.0)
7.3–8.6 140 (17.1) 308 (19.9) 60 (22.2) 127 (25.2) 80 (14.6) 181 (17.4)
>8.6 169 (20.6) 310 (20.0) 56 (20.7) 133 (26.3) 113 (20.6) 177 (17.0)
aQuintiles are based on the control distribution. bThere are a few missing values.reduces arbitrary decisions on the part of the interviewer. Because
only 680 complete case–control triplets were available, a matched
analysis would unduly restrict the number of available subjects.
Furthermore, previous reports found very similar results using
conditional and unconditional logistic regression models.
Therefore, all subjects were included in the present analysis. In
addition, because the comparison of breast cancer cases to either
set of controls produced similar results for previously examined
exposures, the two control groups were combined to improve the
precision of the effect estimates.
A core model was used to control for the potential confounding
effects of established demographic and reproductive risk factors
for breast cancer. These factors include age (years), place of birth
(urban, rural), Quetelet index (kg m–2), parity (parous, nulli-
parous), age at first full-term pregnancy (years; among parous
women), age at menarche (years), menopausal status (post-
menopausal, premenopausal) and total energy intake (quintiles).
Using evenly spaced scores, the trend across the quintile of intake
was assessed by a chi-squared test with one degree of freedom.
The correlation between pairs of energy-adjusted micronutrients
was assessed using Spearman correlation coefficients. In addition,
because the effect of some breast cancer risk factors appears to
vary by menopausal status, we used the likelihood ratio test to test
for interaction between each micronutrient and menopausal status.
Women were defined as post-menopausal if they had not had a
menstrual period in the previous 12 months, were using hormonal
therapy or had had a hysterectomy. Otherwise, women were classi-
fied as pre- or perimenopausal.
RESULTS
The distribution of cases and controls by age, place of birth, body
mass index, parity, age at first birth, age at menarche and
menopausal status is presented in Table 1. The differences between
the case and control distributions are consistent with established
breast cancer risk factors, and these variables are included in all
subsequent multivariate models.
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Table 3 Multiple logistic regression derived odds ratios (OR) and 95% confidence intervals (CI) for the associations between quintile of nutrient intake and
breast cancer, among all women and stratified by menopausal status
Nutrient All women Premenopausal women Post-menopausal women
ORa 95% CI ORb 95% CI ORb 95% CI
Retinol (mg day–1)
≤659.1 1.00c – 1.00 – 1.00 –
659.2–1306.3 0.99 (0.73–1.33) 1.26 (0.71–2.26) 0.89 (0.63–1.27)
1306.4–1575.2 1.03 (0.76–1.39) 1.28 (0.73–2.24) 0.91 (0.64–1.31)
1575.3–2120.7 0.84 (0.61–1.15) 1.18 (0.67–2.05) 0.68 (0.46–1.01)
>2120.7 0.89 (0.65–1.23) 1.16 (0.67–2.01) 0.80 (0.53–1.21)
P-value for trendd 0.31 0.83 0.14
b-carotene (mg day–1)
≤3780.7 1.00 – 1.00 – 1.00 –
3780.8–5185.6 0.83 (0.62–1.12) 0.67 (0.40–1.13) 0.94 (0.66–1.34)
5185.7–6465.4 0.70 (0.52–0.95) 0.73 (0.44–1.20) 0.65 (0.44–0.95)
6465.5–8362.4 0.70 (0.52–0.95) 0.49 (0.29–0.83) 0.83 (0.57–1.21)
>8362.4 0.67 (0.49–0.91) 0.36 (0.21–0.61) 0.90 (0.61–1.35)
P-value for trend 0.005 0.0001 0.38
Vitamin C (mg day–1)
≤142.9 1.00 – 1.00 – 1.00 –
143.0–212.0 1.25 (0.92–1.69) 0.95 (0.54–1.67) 1.38 (0.96–1.98)
212.1–274.0 0.96 (0.69–1.33) 0.96 (0.53–1.72) 0.91 (0.61–1.36)
274.1–343.1 0.83 (0.60–1.17) 0.61 (0.33–1.11) 0.93 (0.61–1.41)
>343.1 0.68 (0.47–0.97) 0.45 (0.24–0.85) 0.80 (0.51–1.26)
P-value for trend 0.002 0.002 0.09
Vitamin E (IU day–1)
≤5.2 1.00 – 1.00 – 1.00 –
5.3–6.2 0.90 (0.65–1.24) 0.86 (0.47–1.59) 0.88 (0.59–1.30)
6.3–7.2 0.89 (0.64–1.26) 1.00 (0.53–1.90) 0.80 (0.53–1.21)
7.3–8.6 0.65 (0.45–0.95) 0.68 (0.35–1.33) 0.61 (0.38–0.96)
>8.6 0.71 (0.48–1.05) 0.50 (0.25–1.02) 0.85 (0.53–1.36)
P-value for trend 0.04 0.03 0.25
aThe nutrients in the table are not mutually adjusted; the model includes variables for age (years), birth place (urban vs rural), body mass index (kg m–2), parity
(parous vs nulliparous), age at first birth (years; among parous women), age at menarche (years), menopausal status (pre- vs postmenopausal), and total
energy intake (quintiles). bAdjusted for all variables in a except for menopausal status. cReference category. dTest for trend is from a multivariate model in which
nutrient intake is included as an ordinal variable with values 1–5.
Table 4 Correlations between pairs of energy-adjusted micronutrient
intakes among the controls
Retinol b-Carotene Vitamin C Vitamin E
Retinol
b-carotene 0.003
Vitamin C –0.08 0.49
Vitamin E 0.12 0.26 0.24The likelihood ratio tests of the interactions between
menopausal status and intake of each micronutrient in relation to
risk of breast cancer were significant for b-carotene, vitamin C and
vitamin E, but not for retinol (data not shown). Therefore, all
results are presented separately for pre- and post-menopausal
women, as well as for all women combined.
Total energy intake was slightly higher among cases than among
controls, but this may reflect over-reporting (which is adjusted for
when energy intake is accounted for). Cases consumed an average
of 1939 kcal per day, compared with 1905 kcal per day among the
controls. When risk of breast cancer by quintile of total energy
intake was considered, it was not clear whether log-risk changed
in a log-linear manner across the quintiles (data not shown).
Therefore, total energy intake was modelled as a categorical,
rather than continuous, variable.
Table 2 presents the crude frequency distribution of cases and
controls by control-defined quintile of each micronutrient of
interest. The multiple logistic regression-derived odds ratios (OR)
and 95% confidence intervals (95% CI) by quintile of intake are
presented in Table 3. The micronutrients in this table are not mutu-
ally adjusted, but are adjusted for total energy intake and the vari-
ables in Table 1. Retinol is not associated with risk of breast cancer
in either pre- or post-menopausal women. For b-carotene, vitamin
C and vitamin E, there are significant inverse trends with
increasing intake among premenopausal women only. The
strongest inverse association is observed for b-carotene: among
premenopausal women, the odds ratio for the highest quintile of b-
carotene intake relative to the lowest quintile is 0.36 (95% CI
0.21–0.61), with a P-value for the trend across quintiles of 0.0001.
Among post-menopausal women, those in the highest quintiles of
intake of b-carotene, vitamin C and vitamin E had a non-signifi-
cant reduction in risk; in no case was the trend across quintiles
significant among post-menopausal women. Further adjustment
for alcohol intake and use of post-menopausal hormones did not
materially alter the results in Table 3, nor did adjustment for total
energy intake as a continuous, rather than categorical, variable
(data not shown). Differences between the crude associations in
Table 2 and the adjusted associations in Table 3 are due to possible
confounding of the crude associations, in part by the constellation
of risk factors and in part by the higher energy intake among the
cases (genuine or, to a certain extent, explained by over-reporting).
Although the results of Table 3 are compatible with a protective
role among premenopausal women for three of the four micro-
nutrients evaluated, the correlations among the micronutrients
must be considered. Table 4 presents the Spearman correlation
coefficients, among controls, for the micronutrients of interest.
Beta-carotene and vitamin C are the most highly correlated vari-
ables, with r = 0.49. Given this degree of correlation, the effect of
mutual adjustment among the micronutrients is of interest. Table 5
presents both the non-mutually adjusted and mutually adjusted
odds ratios and 95% confidence intervals for a one-quintile
increase in intake for b-carotene, vitamin C and vitamin E, among
all women and after stratification by menopausal status. Although
the effect of each micronutrient is attenuated after mutual adjust-
ment, the effect of b-carotene remains significant among
premenopausal women; the odds ratio for a one-quintile increase
in intake is 0.84 (95% CI 0.73–0.97). This apparent effect is
stronger than those of vitamin C and vitamin E. As before, none of
the associations achieved statistical significance among post-
menopausal women.
DISCUSSION
The results of the present analysis suggest an inverse association
between breast cancer and b-carotene intake among premenopausal
women. Vitamins C and E also appear inversely associated with
breast cancer risk among premenopausal women, but the effect of
each is substantially attenuated upon adjustment for b-carotene.
There was no effect of retinol intake among premenopausal
women. Among post-menopausal women, there is some suggestion
of an inverse association with each of the micronutrients evaluated,
but none of these associations was statistically significant.
Bias and confounding must be considered as possible explana-
tions for the observed results. The documentation in this study of
established breast cancer risk factors argues against selection bias.
Recall bias is always a concern in case–control studies, but lack of
awareness among women in this population of any link between
fruit and vegetable intake and risk of breast cancer should mini-
mize this problem. However, the fact that cohort studies generally
have observed weaker associations for these nutrients than
case–control studies raises the possibility that recall bias may still
play a role.
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Table 5 Multiple logistic regression derived odds ratios (OR) and 95% confidence intervals (CI) for a one-quintile increase in micronutrient intake, without and
with mutual adjustment among micronutrients, among all women and stratified by menopausal status
All women Premenopausal women Post-menopausal women
ORa 95% CI ORb 95% CI ORb 95% CI
Without mutual adjustment
b-Carotene 0.90 (0.84–0.97) 0.79 (0.70–0.89) 0.96 (0.88–1.05)
Vitamin C 0.88 (0.81–0.96) 0.80 (0.70–0.92) 0.92 (0.83–1.01)
Vitamin E 0.91 (0.83–0.99) 0.84 (0.72–0.98) 0.94 (0.84–1.05)
With mutual adjustment
b-Carotene 0.95 (0.87–1.03) 0.84 (0.73–0.97) 1.00 (0.90–1.11)
Vitamin C 0.92 (0.84–1.01) 0.90 (0.77–1.05) 0.92 (0.82–1.04)
Vitamin E 0.95 (0.86–1.04) 0.93 (0.79–1.10) 0.95 (0.85–1.07)
aThe model includes variables for age (years), birth place (urban vs rural), body mass index (kg m–2), parity (parous vs nulliparous), age at first birth (years;
among parous women), age at menarche (years), menopausal status (pre- vs post-menopausal) and total energy intake (quintile). bAdjusted for all variables in a
except for menopausal status.Strengths of the study include the high variability in intake of
fruits and vegetables and their component nutrients in the study
population, as well as the high absolute intake of these foods. The
wide range of intake improves the power to detect effects, whereas
the high absolute intake of nutritional factors that may have
growth-controlling, rather than initiation-limiting, properties
suggests that possible exposure thresholds are likely to be
exceeded.
Previous case–control studies generally support an inverse asso-
ciation with carotenoid intake. Of 18 case–control studies, 14
(LaVecchia et al, 1987; Katsouyanni et al, 1988; Rohan et al, 1988;
Iscovich et al, 1989; van ’t Veer et al, 1990; Graham et al, 1991;
Ingram et al, 1991; Lee et al, 1991; Zaridze et al, 1991; London et
al, 1992; Levi et al, 1993; Holmberg et al, 1994; Freudenheim
et al, 1996; Negri et al, 1996) observed a reduced risk of breast
cancer among those in the highest category of carotenoid intake,
whereas four (Marubini et al, 1988; Toniolo et al, 1989; Ewertz and
Gill, 1990; Richardson et al, 1991) observed no reduction in risk.
Of the inverse associations, six (Graham et al, 1991; Lee et al,
1991; Zaridze et al, 1991; Holmberg et al, 1994; Freudenheim et al,
1996; Negri et al, 1996) were statistically significant. A combined
analysis of the data from eight case–control studies reported an
odds ratio of 0.85 (P = 0.007) for the highest versus the lowest
quintile of carotenoid intake (Howe et al, 1990). The results from
six prospective studies are weaker; four (Paganini-Hill et al, 1987;
Graham et al, 1992; Hunter et al, 1993; Rohan et al, 1993)
observed inverse but non-significant associations, and two (Kushi
et al, 1996; Verhoeven et al, 1997) found no evidence of an inverse
association. Although the majority of the case–control and cohort
studies did not evaluate specific carotenoids other than b-carotene,
one recent case–control study presented results for several
carotenoids. Freudenheim et al (1996) report significant inverse
associations with b-carotene,  a-carotene and lutein–zeaxanthin.
The association with lycopene was inverse but not statistically
significant, and no association was observed with b-cryptoxanthin.
Although clinical trial data are not yet available regarding the
effect of b-carotene supplementation on risk of breast cancer, b-
carotene supplementation has been assessed in relation to cancer at
other sites. The outcomes of these trials have differed. A trial of b-
carotene supplementation in relation to premalignant oral lesions
suggested that b-carotene may promote regression of the lesions
(Sankaranarayanan et al, 1997). Two other trials, primarily among
smokers, reported an increased risk of lung cancer among those
receiving  b-carotene (The Alpha-Tocopherol, Beta-Carotene
Cancer Prevention Study Group, 1994) or b-carotene in combina-
tion with retinyl palmitate (Omenn et al, 1996). A third trial found
no association between b-carotene supplementation and risk of
lung cancer or other malignant neoplasms (Hennekens et al, 1996).
Two trials of b-carotene supplementation in relation to recurrent
skin cancer (Greenberg et al, 1990) and colon polyps (Greenberg
et al, 1994) also reported no association.
Of 13 case–control studies to evaluate vitamin C intake, eight
(Iscovich et al, 1989; Graham et al, 1991; Zaridze et al, 1991; Levi
et al, 1993; Landa et al, 1994; Yuan et al, 1995; Freudenheim et al,
1996; Negri et al, 1996) report odds ratios of less than 0.8, and five
(Graham et al, 1982; Katsouyanni et al, 1988; Toniolo et al, 1989;
Ingram et al, 1991; Holmberg et al, 1994) report odds ratios greater
than or equal to 1.0. Howe et al (1990), in a combined analysis of
the data from nine case–control studies, reported an odds ratio of
0.69 (P<0.0001) for the highest quintile of vitamin C intake. Three
prospective studies (Graham et al, 1992; Rohan et al, 1993;
Verhoeven et al, 1997) observed relative risks of less than 0.90,
although another two (Hunter et al, 1993; Kushi et al, 1996) did
not. None of the results from prospective studies were statistically
significant.
Fewer studies have evaluated vitamin E intake. Of ten
case–control studies, seven (Graham et al, 1991; Lee et al, 1991;
London et al, 1992; Holmberg et al, 1994; Yuan et al, 1995;
Freudenheim et al, 1996; Negri et al, 1996) suggest an inverse
association with vitamin E intake and three (Toniolo et al, 1989;
Gerber et al, 1990; Richardson et al, 1991) report null or positive
associations; the results are statistically significant in four
(Graham et al, 1991; London et al, 1992; Freudenheim et al, 1996;
Negri et al, 1996) of the studies reporting inverse associations. The
results from cohort studies are decidedly weaker: of five studies
(Graham et al, 1992; Hunter et al, 1993; Rohan et al, 1993; Kushi
et al, 1996; Verhoeven et al, 1997), only one (Graham et al, 1992)
reports a relative risk of less than 0.90, and this was not statisti-
cally significant.
A handful of studies report a protective association with retinol,
but the overall picture is one of a null or even positive association
with breast cancer. Of 13 case–control studies, six (La Vecchia
et al, 1987; Katsouyanni et al, 1988; Marubini et al, 1988; Zaridze
et al, 1991; London et al, 1992; Negri et al, 1996) report inverse
associations, and seven (Rohan et al, 1988; Toniolo et al, 1989;
Graham et al, 1991; Ingram et al, 1991; Richardson et al, 1991;
Levi et al, 1993; Yuan et al, 1995) report null or positive findings.
Of the case–control studies reporting inverse associations, only
one (Negri et al, 1996) approaches statistical significance at the
highest category of intake. Of the case–control studies reporting
null or positive associations, Richardson et al (1991) report a
statistically significant increased risk at the highest category of
intake among post-menopausal women (OR = 2.8, 95% CI 1.2–
2.8). In a combined analysis of seven case–control studies, Howe
et al (1990) report an odds ratio of 1.04 for the highest quintile of
retinol intake. Of five prospective studies, two (Hunter et al, 1993;
Rohan et al, 1993) report inverse associations with retinol intake,
and three (Graham et al, 1992; Kushi et al, 1996; Verhoeven et al,
1997) report null or positive associations. The only statistically
significant finding from a prospective study is reported by Hunter
et al (1993), in which the relative risk for the highest quintile of
intake is 0.80 (95% CI 0.68–0.95).
Plausible biological mechanisms by which each of these
micronutrients may affect breast cancer risk do exist, although
none of these mechanisms has been shown to be of importance in
the development of breast cancer in humans. b-carotene and other
carotenoids are potent antioxidants (Peto et al, 1981; Ames, 1983)
and may protect against free radical-induced DNA damage.
Vitamin E is a lipid-soluble antioxidant that protects against lipid
peroxidation of cell membranes (Ames, 1983). Vitamin C is a
water-soluble antioxidant that may also play a role in immune
function and in the sparing of other antioxidants, including vitamin
E (Block, 1991). With the exception of retinol, results for each of
the micronutrients assessed were more strongly inversely associ-
ated with breast cancer risk among premenopausal than among
post-menopausal women. The reasons for this are not clear, but the
proximity of younger women to the aetiologically relevant time
period is a possible explanation. Several previous studies have
considered differences by menopausal status in the effect of
micronutrients (La Vecchia et al, 1987; Katsouyanni et al, 1988;
Marubini et al, 1988; Rohan et al, 1988; Howe et al, 1990;
Richardson et al, 1991; Zaridze et al, 1991; Lee et al, 1992; Hunter
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tent results. Approximately half of all studies reporting results by
menopausal status indicate no differences in pre- and post-
menopausal women (La Vecchia et al, 1987; Katsouyanni et al,
1988; Marubini et al, 1988; Rohan et al, 1993; Yuan et al, 1995).
Of studies that found even a modest difference by menopausal
status, one (Zaridze et al, 1991) reported stronger protective
effects among post-menopausal women, and three (Rohan et al,
1988; Lee et al, 1992; Hunter et al, 1993) reported stronger protec-
tive effects among premenopausal women for at least one nutrient.
Howe et al (1990), in a combined analysis of the data from 12
case–control studies, reported that the protective effects of b-
carotene and vitamin C were stronger among post-menopausal
women than among premenopausal women, although the tests for
heterogeneity were not significant. In light of these inconsisten-
cies, and without a strong basis for the apparent effect modifica-
tion, the differences by menopausal status observed in the present
study should be interpreted cautiously.
Although the current and several previous studies have found an
inverse association between b-carotene and breast cancer, one must
consider the extent to which the observed effect is because of the
nutrient per se, and the extent to which it can be explained by the
correlation of the nutrient with other unmeasured components of
fruits and vegetables. Several previous studies, reviewed by Potter
and Steinmetz (1996), have indicated that high intake of fruits and
vegetables may be associated with a reduced risk of breast cancer.
If the protection conferred by fruits and vegetables is attributable to
one of the micronutrients evaluated, the absolute value of the effect
estimate for the micronutrient (per quintile or other centile) should
be larger than the corresponding estimate for fruits and vegetables.
In a previously published report from this study, the logistic regres-
sion parameter estimate for a one-quintile increase in vegetable
intake was –0.1374 (Trichopoulou et al, 1995), whereas in the
current analysis the estimate for a one-quintile increase in b-
carotene intake is a weaker –0.1014. Definitive conclusions,
however, cannot be drawn from these findings. First, b-carotene
intake is measured with greater error than fruit and vegetable
intake, and the resulting attenuation of the b-carotene effect may
mask a stronger effect. It, therefore, may not be possible to rule out
b-carotene as a principal protective component of fruits and vegeta-
bles. Second, the weaker effect of b-carotene may indicate that b-
carotene is only one of many micronutrients that contribute to the
protection conferred by vegetable intake. Third and final, b-
carotene may have no effect on breast cancer risk; the observed
protective effect may be explained entirely by another component
of fruits and vegetables that is correlated with b-carotene intake. A
variety of such substances are discussed in a review by Steinmetz
and Potter (1991). Given these various possibilities, it would be
premature to consider b-carotene as playing a major role in
reducing breast cancer risk.
Although the effect of vitamin E was not statistically significant,
it was clearly inverse. In this population of Greek women, olive oil
is an important source of vitamin E. A previously published report
from this study demonstrated a statistically significant inverse
association between olive oil intake and risk of breast cancer
(Trichopoulou et al, 1995). This association is stronger than that of
vitamin E, suggesting that vitamin E itself may not be the sole
explanation for the apparent protection conferred by olive oil.
In conclusion, the present analysis did not demonstrate a strong
independent effect on breast cancer risk of any of the micro-
nutrients evaluated. A protective effect of b-carotene intake was
observed among premenopausal women, but it is not possible to
rule out the possibility that this apparent effect is due, at least in
part, to other components of fruits and vegetables. In light of these
data, the most prudent public health message would be to increase
intake of fruits and vegetables. Supplementation with b-carotene,
although probably not harmful, has no clear indication in the
context of breast cancer risk.
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